Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Childhood Solid Tumor × Capecitabine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 221 Colorectal Neoplasms 192 Rectal Neoplasms 171 Stomach Neoplasms 116 Pancreatic Neoplasms 100 Neoplasm Metastasis 77 Colonic Neoplasms 58 Neoplasms 50 Esophageal Neoplasms 39 Triple Negative Breast Neoplasms 38 Biliary Tract Neoplasms 27 Nasopharyngeal Carcinoma 26 Cholangiocarcinoma 22 Gallbladder Neoplasms 20 Carcinoma, Hepatocellular 17 Locally Advanced Rectal Cancer 16 Adenocarcinoma 15 Gastrointestinal Neoplasms 13 Colorectal Cancer Metastatic 13 Head and Neck Neoplasms 12 Bile Duct Neoplasms 12 Adenocarcinoma Of Esophagus 12 Esophageal Squamous Cell Carcinoma 11 Breast Neoplasms, Male 11 Brain Neoplasms 11 Liver Neoplasms 10 Carcinoma, Renal Cell 10 Neuroendocrine Tumors 9 Unspecified Adult Solid Tumor, Protocol Specific 8 Squamous Cell Carcinoma of Head and Neck 8

Interventions

Vinblastine 1 Surveys and Questionnaires 1 Nivolumab 1 Cyclophosphamide 1 Cell- and Tissue-Based Therapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03585465 2026-03-18

Metro-PD1

Centre Oscar Lambret

Phase 1/2 Active not recruiting

Other solid neoplasm

Childhood Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡